Synopsys (NASDAQ:SNPS) Price Target Raised to $620.00

by · The Markets Daily

Synopsys (NASDAQ:SNPS – Free Report) had its price objective raised by Needham & Company LLC from $580.00 to $620.00 in a research note published on Monday, Marketbeat.com reports. The brokerage currently has a buy rating on the semiconductor company’s stock.

Other research analysts also recently issued reports about the stock. Weiss Ratings downgraded shares of Synopsys from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday, September 11th. Rothschild & Co Redburn lowered their target price on shares of Synopsys from $560.00 to $550.00 and set a “buy” rating on the stock in a report on Wednesday, September 23rd. JPMorgan Chase & Co. dropped their target price on Synopsys from $650.00 to $600.00 in a research report on Thursday, August 27th. UBS Group set a $570.00 target price on Synopsys in a research report on Thursday, August 27th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $640.00 price target (up from $590.00) on shares of Synopsys in a report on Thursday, October 1st. One equities research analyst has rated the stock with a Strong Buy rating, twenty-one have assigned a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $571.78.

Check Out Our Latest Stock Analysis on Synopsys

Synopsys Stock Performance

Shares of SNPS opened at $479.93 on Monday. The firm has a market cap of $91.97 billion, a PE ratio of 50.26, a PEG ratio of 2.02 and a beta of 1.21. The stock’s fifty day moving average price is $425.55 and its two-hundred day moving average price is $440.80. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.34 and a quick ratio of 1.24. Synopsys has a 1 year low of $362.55 and a 1 year high of $539.48.

Synopsys (NASDAQ:SNPS – Get Free Report) last posted its quarterly earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share for the quarter, topping the consensus estimate of $3.67 by $0.24. Synopsys had a return on equity of 6.24% and a net margin of 11.43%. The company had revenue of $2.48 billion during the quarter, compared to the consensus estimate of $2.44 billion. During the same quarter in the prior year, the company earned $3.39 EPS. The firm’s quarterly revenue was up 42.4% compared to the same quarter last year. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. On average, equities research analysts forecast that Synopsys will post 10.97 EPS for the current year.

Synopsys announced that its board has authorized a share buyback program on Monday, October 5th that permits the company to buy back $1.00 billion in outstanding shares. This buyback authorization permits the semiconductor company to purchase up to 1.1% of its stock through open market purchases. Share buyback programs are often an indication that the company’s board of directors believes its stock is undervalued.

Insider Activity

In other Synopsys news, CEO Sassine Ghazi sold 14,604 shares of the stock in a transaction that occurred on Tuesday, September 15th. The shares were sold at an average price of $374.88, for a total value of $5,474,747.52. Following the sale, the chief executive officer directly owned 76,865 shares in the company, valued at $28,815,151.20. This represents a 15.97% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Sudhindra Kankanwadi sold 9,170 shares of the firm’s stock in a transaction on Tuesday, October 6th. The shares were sold at an average price of $500.00, for a total transaction of $4,585,000.00. Following the completion of the transaction, the chief financial officer directly owned 22,717 shares of the company’s stock, valued at approximately $11,358,500. The trade was a 28.76% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 102,559 shares of company stock worth $44,607,141. Insiders own 0.56% of the company’s stock.

Institutional Investors Weigh In On Synopsys

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in shares of Synopsys during the second quarter valued at approximately $747,400,000. Man Group plc bought a new stake in shares of Synopsys during the second quarter valued at approximately $55,900,000. Nykredit A S purchased a new position in Synopsys in the 2nd quarter worth approximately $23,158,000. Bank of America Corp DE purchased a new position in Synopsys in the 2nd quarter worth approximately $539,986,000. Finally, Integrated Wealth Concepts LLC raised its holdings in Synopsys by 88.6% in the 2nd quarter. Integrated Wealth Concepts LLC now owns 6,816 shares of the semiconductor company’s stock worth $3,040,000 after acquiring an additional 3,202 shares during the last quarter. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Synopsys Company Profile

(Get Free Report)

Synopsys, Inc is a technology company that develops electronic design automation (EDA) software, semiconductor intellectual property (IP), and software tools used to design, verify, and manufacture advanced electronic systems. Its solutions support the development of semiconductors, systems-on-chip, and electronic products across the design cycle, from initial specification and architecture through testing and production.

The company’s offerings include digital and custom integrated-circuit design tools, simulation and verification software, physical design and signoff products, and semiconductor IP such as processor cores, interface technologies, and foundational components.

See Also